We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$210M
AUM Growth
+$7.69M
Cap. Flow
+$4.27M
Cap. Flow %
2.03%
Top 10 Hldgs %
44.48%
Holding
178
New
16
Increased
72
Reduced
69
Closed
10

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$840K
2
AAPL icon
Apple
AAPL
+$728K
3
MO icon
Altria Group
MO
+$501K
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$439K
5
SNAP icon
Snap
SNAP
+$408K

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$516K
2
AMZN icon
Amazon
AMZN
+$363K
3
QCOM icon
Qualcomm
QCOM
+$343K
4
VMC icon
Vulcan Materials
VMC
+$287K
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$239K

Sector Composition

Rank Sector Weight
1 Technology 11.78%
2 Communication Services 11.14%
3 Healthcare 9.45%
4 Consumer Discretionary 7.27%
5 Industrials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
26
NVIDIA
NVDA
$4.86T
$1.92M 0.91%
436,920
+58,800
+16% +$244K
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.89M 0.9%
11,187
+1,073
+11% +$190K
BIIB icon
28
Biogen
BIIB
$30B
$1.67M 0.79%
5,383
+338
+7% +$100K
EFA icon
29
iShares MSCI EAFE ETF
EFA
$78B
$1.62M 0.77%
23,845
-1,188
-5% -$79.4K
JPM icon
30
JPMorgan Chase
JPM
$935B
$1.61M 0.77%
16,910
+473
+3% +$43.6K
PML
31
PIMCO Municipal Income Fund II
PML
$485M
$1.55M 0.74%
117,867
+8,374
+8% +$111K
TSLA icon
32
Tesla
TSLA
$1.23T
$1.43M 0.68%
63,030
+12,960
+26% +$299K
ATVI
33
DELISTED
Activision Blizzard
ATVI
$1.41M 0.67%
22,185
+3,625
+20% +$226K
JNJ icon
34
Johnson & Johnson
JNJ
$618B
$1.4M 0.67%
10,822
+368
+4% +$48.8K
PM icon
35
Philip Morris
PM
$297B
$1.38M 0.66%
12,352
-99
-0.8% -$11.5K
NMZ icon
36
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
$1.37M 0.65%
101,415
+15,043
+17% +$204K
V icon
37
Visa
V
$684B
$1.36M 0.65%
13,029
+398
+3% +$40.4K
LABU icon
38
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$506M
$1.33M 0.63%
794
-130
-14% -$180K
CURE icon
39
Direxion Daily Healthcare Bull 3X ETF
CURE
$178M
$1.25M 0.6%
28,018
-1,377
-5% -$59.4K
CVX icon
40
Chevron
CVX
$392B
$1.13M 0.54%
9,603
+349
+4% +$38.1K
AMGN icon
41
Amgen
AMGN
$208B
$1.12M 0.53%
6,025
+350
+6% +$62K
PFE icon
42
Pfizer
PFE
$143B
$1.11M 0.53%
32,786
-257
-0.8% -$8.26K
IBB icon
43
iShares Biotechnology ETF
IBB
$9.34B
$1.11M 0.53%
10,035
-1,089
-10% -$116K
FNCL icon
44
Fidelity MSCI Financials Index ETF
FNCL
$2.38B
$998K 0.47%
26,371
-2,202
-8% -$80.7K
TNA icon
45
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.3B
$967K 0.46%
14,984
+499
+3% +$27.8K
MIDU icon
46
Direxion Daily Mid Cap Bull 3X ETF
MIDU
$68.7M
$957K 0.46%
23,824
-2,549
-10% -$94.7K
PGP
47
PIMCO Global StockPLUS & Income Fund
PGP
$98.1M
$954K 0.45%
57,655
+5,705
+11% +$97.6K
TSS
48
DELISTED
Total System Services, Inc.
TSS
$937K 0.45%
14,409
– –
T icon
49
AT&T
T
$159B
$892K 0.42%
30,173
+39
+0.1% +$1.11K
LUV icon
50
Southwest Airlines
LUV
$22B
$888K 0.42%
15,814
-692
-4% -$38.8K
1
2
3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM

Traynor Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Traynor Capital Management held 178 positions worth $210M, up 3.8% from $203M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Traynor Capital Management's Q3 2017 filing shows 16 new, 72 increased, 69 reduced and 10 closed positions. Its largest new stake was Teva Pharmaceuticals: 19,502 shares worth $335K. The largest sale was Alnylam Pharmaceuticals, an estimated $516K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Communication Services and Healthcare.

  • Traynor Capital Management's largest Q3 2017 buy was Teva Pharmaceuticals: 19,502 shares worth $335K.
  • Traynor Capital Management added most to Intuitive Surgical in Q3 2017, an estimated $840K increase.
  • Traynor Capital Management's biggest Q3 2017 reduction was Amazon, cutting an estimated $363K.
  • Traynor Capital Management fully exited Alnylam Pharmaceuticals in Q3 2017, selling an estimated $516K.
  • Traynor Capital Management's ten largest holdings make up 44% of its $210M portfolio in Q3 2017.
  • Traynor Capital Management opened 16 new positions and closed 10 in Q3 2017.
  • Traynor Capital Management's portfolio value rose 3.8% quarter-over-quarter to $210M.

Based on Traynor Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.